We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGEM icon
476
Cullinan Oncology
CGEM
$1.05B
$20.6M 0.03%
1,184,037
+1,136,993
+2,417% +$24.2M
YOU icon
477
Clear Secure
YOU
$5.26B
$20.6M 0.03%
1,099,062
+808,515
+278% +$14.6M
CPRI icon
478
Capri Holdings
CPRI
$1.77B
$20.6M 0.03%
621,470
-248,383
-29% -$8.98M
ARCB icon
479
ArcBest
ARCB
$3.44B
$20.6M 0.03%
191,987
+117,774
+159% +$14.2M
HLF icon
480
Herbalife
HLF
$1.23B
$20.5M 0.03%
1,977,155
+1,885,346
+2,054% +$18.8M
VTR icon
481
Ventas
VTR
$48.9B
$20.5M 0.03%
+399,150
New +$18.7M
IEX icon
482
IDEX
IEX
$16.5B
$20.4M 0.03%
101,558
+62,803
+162% +$13.7M
GGB icon
483
Gerdau
GGB
$9.44B
$20.4M 0.03%
6,186,152
+5,830,665
+1,640% +$20.6M
YUMC icon
484
Yum China
YUMC
$14.9B
$20M 0.03%
+649,879
New +$23.8M
ELAN icon
485
Elanco Animal Health
ELAN
$12.4B
$20M 0.03%
1,385,115
-5,497,626
-80% -$87.8M
AEP icon
486
American Electric Power
AEP
$73.7B
$19.9M 0.03%
+226,254
New +$19.8M
PTGX icon
487
Protagonist Therapeutics
PTGX
$8.75B
$19.8M 0.03%
572,177
-404,716
-41% -$11.9M
CUZ icon
488
Cousins Properties
CUZ
$5.29B
$19.8M 0.03%
853,456
+410,726
+93% +$9.45M
PUK icon
489
Prudential
PUK
$36.5B
$19.7M 0.03%
1,076,579
+128,124
+14% +$2.42M
HSY icon
490
Hershey
HSY
$35.4B
$19.7M 0.03%
107,234
-75,733
-41% -$14.7M
FRT icon
491
Federal Realty Investment Trust
FRT
$10.9B
$19.7M 0.03%
195,030
+50,590
+35% +$5.11M
WM icon
492
Waste Management
WM
$95.9B
$19.6M 0.03%
91,940
-10,159
-10% -$2.11M
CROX icon
493
Crocs
CROX
$6.69B
$19.6M 0.03%
+134,288
New +$18.8M
BOOT icon
494
Boot Barn
BOOT
$4.55B
$19.5M 0.03%
+151,490
New +$17.1M
RXST icon
495
RxSight
RXST
$215M
$19.5M 0.03%
+324,289
New +$18.5M
ETN icon
496
Eaton
ETN
$157B
$19.5M 0.03%
62,182
-9,931
-14% -$3.21M
GO icon
497
Grocery Outlet
GO
$891M
$19.5M 0.03%
880,870
-111,093
-11% -$2.63M
RVMDW icon
498
CALL
Revolution Medicines Inc Warrant
RVMDW
$105M
$19.4M 0.03%
500,000
-2,947
-0.6% -$611
PEN icon
499
Penumbra
PEN
$12.5B
$19.4M 0.03%
107,692
+87,257
+427% +$17.4M
SMPL icon
500
Simply Good Foods
SMPL
$904M
$19.4M 0.03%
536,174
+393,720
+276% +$14.1M

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.